<!doctype html>
<style>
@charset "utf-8";
body {
	height: 100%;
	margin: 0;
	padding: 0;
}

.banner {
	position: fixed;
	top: 0;
	width: 100%;
	height: 65px;
	background: gray;
	line-height: 65px;
}
.spacer {
	height: 10px;
}

.main-content {
	padding: 5%;
}

.collapse_ACT {
	cursor: pointer;
	display: block;
	color: black;
	height: 30px;
	line-height: 30px;
	border-style: none solid none none;
	border-color: #B4045F;
	border-width: thick;
	background: #DCDCDC;
}
.collapse_ACT + input{
	display: none;
}
.collapse_ACT + input + div{
	display: none;
}
.collapse_ACT + input:checked + div{
	display: block;
}
.ACT {
	text-align: justify;
	text-justify: inter-word;
}
.ACT_collapse_similarity {
	cursor: pointer;
	display: block;
	color: black;
	background: white;
	border-style: none none none solid;
	border-color: #B4045F;
}
.ACT_collapse_similarity:hover{
	background: #e5d3dc;
}
.ACT_collapse_similarity + input {
	display: none;
}
.ACT_collapse_similarity + input + div{
	display: none;
}

.ACT_collapse_similarity + input:checked + div{
	display: block;
}
.ACT_collapse_similarity > a {
	text-decoration: none;
	color: gray;
}
.ACT_collapse_similarity {
	cursor: pointer;
	display: block;
	color: black;
	background: white;
	border-style: none none none solid;
	border-color: #B4045F;
	padding-left: 5px;
}
.ACT_collapse_similarity:hover{
	background: #e5d3dc;
}
.ACT_collapse_similarity + input {
	display: none;
}
.ACT_collapse_similarity + input + div{
	display: none;
}
.ACT_collapse_similarity + input:checked + div{
	display: block;
}
.ACT_collapse_similarity > a {
	text-decoration: none;
	color: gray;
}
.ACT_similar {
	padding-left: 2%;
	text-align: justify;
	text-justify: inter-word;
	border-style: none none none solid;
	border-color: #B4045F;
}
.ACT_similar > a {
	text-decoration: none;
	color: gray;
}

.collapse_DOM {
	cursor: pointer;
	display: block;
	color: black;
	height: 30px;
	line-height: 30px;
	border-style: none solid none none;
	border-color: #B404AE;
	border-width: thick;
	background: #DCDCDC;
}
.collapse_DOM + input{
	display: none;
}
.collapse_DOM + input + div{
	display: none;
}
.collapse_DOM + input:checked + div{
	display: block;
}
.DOM {
	text-align: justify;
	text-justify: inter-word;
}
.DOM_collapse_similarity {
	cursor: pointer;
	display: block;
	color: black;
	background: white;
	border-style: none none none solid;
	border-color: #B404AE;
	padding-left: 5px;
}
.DOM_collapse_similarity:hover{
	background: #e8d7e7;
}
.DOM_collapse_similarity + input {
	display: none;
}
.DOM_collapse_similarity + input + div{
	display: none;
}
.DOM_collapse_similarity + input:checked + div{
	display: block;
}
.DOM_collapse_similarity > a {
	text-decoration: none;
	color: gray;
}.DOM_similar {
	padding-left: 2%;
	text-align: justify;
	text-justify: inter-word;
	border-style: none none none solid;
	border-color: #B404AE;
}
.DOM_similar > a {
	text-decoration: none;
	color: gray;
}

.collapse_EVO {
	cursor: pointer;
	display: block;
	color: black;
	height: 30px;
	line-height: 30px;
	border-color: #7401DF;
	border-style: none solid none none;
	border-width: thick;
	background: #DCDCDC;
}
.collapse_EVO + input{
	display: none;
}
.collapse_EVO + input + div{
	display: none;
}
.collapse_EVO + input:checked + div{
	display: block;
}
.EVO {
	text-align: justify;
	text-justify: inter-word;
}
.EVO_collapse_similarity {
	cursor: pointer;
	display: block;
	color: black;
	background: white;
	border-style: none none none solid;
	border-color: #7401DF;
	padding-left: 5px;
}
.EVO_collapse_similarity:hover{
	background: #e2d7ed;
}
.EVO_collapse_similarity + input {
	display: none;
}
.EVO_collapse_similarity + input + div{
	display: none;
}
.EVO_collapse_similarity + input:checked + div{
	display: block;
}
.EVO_collapse_similarity > a {
	text-decoration: none;
	color: gray;
}
.EVO_similar {
	padding-left: 2%;
	text-align: justify;
	text-justify: inter-word;
	border-style: none none none solid;
	border-color: #7401DF;
}
.EVO_similar > a {
	text-decoration: none;
	color: gray;
}

.collapse_RP {
	cursor: pointer;
	display: block;
	color: black;
	height: 30px;
	line-height: 30px;
	border-color: #0174DF;
	border-style: none solid none none;
	border-width: thick;
	background: #DCDCDC;
}
.collapse_RP + input{
	display: none;
}
.collapse_RP + input + div{
	display: none;
}
.collapse_RP + input:checked + div{
	display: block;
}
.RP {
	text-align: justify;
	text-justify: inter-word;
}
.RP_collapse_similarity {
	cursor: pointer;
	display: block;
	color: black;
	background: white;
	border-style: none none none solid;
	border-color: #0174DF;
	padding-left: 5px;
}
.RP_collapse_similarity:hover{
	background: #c9d7e2;
}
.RP_collapse_similarity + input {
	display: none;
}
.RP_collapse_similarity + input + div{
	display: none;
}
.RP_collapse_similarity + input:checked + div{
	display: block;
}
.RP_collapse_similarity > a {
	text-decoration: none;
	color: gray;
}
.RP_similar {
	padding-left: 2%;
	text-align: justify;
	text-justify: inter-word;
	border-style: none none none solid;
	border-color: #0174DF;
}
.RP_similar > a {
	text-decoration: none;
	color: gray;
}

.collapse_SIT {
	cursor: pointer;
	display: block;
	color: black;
	height: 30px;
	line-height: 30px;
	border-color: #0489B1;
	border-style: none solid none none;
	border-width: thick;
	background: #DCDCDC;
}
.collapse_SIT + input{
	display: none;
}
.collapse_SIT + input + div{
	display: none;
}
.collapse_SIT + input:checked + div{
	display: block;
}
.SIT {
	text-align: justify;
	text-justify: inter-word;
}
.SIT_collapse_similarity {
	cursor: pointer;
	display: block;
	color: black;
	background: white;
	border-style: none none none solid;
	border-color: #0489B1;
	padding-left: 5px;
}
.SIT_collapse_similarity:hover{
	background: #d0dfe2;
}
.SIT_collapse_similarity + input {
	display: none;
}
.SIT_collapse_similarity + input + div{
	display: none;
}
.SIT_collapse_similarity + input:checked + div{
	display: block;
}
.SIT_collapse_similarity > a {
	text-decoration: none;
	color: gray;
}
.SIT_similar {
	padding-left: 2%;
	text-align: justify;
	text-justify: inter-word;
	border-style: none none none solid;
	border-color: #0489B1;
}
.SIT_similar > a {
	text-decoration: none;
	color: gray;
}

.collapse_TU {
	cursor: pointer;
	display: block;
	color: black;
	height: 30px;
	line-height: 30px;
	border-color: #04B486;
	border-style: none solid none none;
	border-width: thick;
	background: #DCDCDC;
}
.collapse_TU + input{
	display: none;
}
.collapse_TU + input + div{
	display: none;
}
.collapse_TU + input:checked + div{
	display: block;
}
.TU {
	text-align: justify;
	text-justify: inter-word;
}
.TU_collapse_similarity {
	cursor: pointer;
	display: block;
	color: black;
	background: white;
	border-style: none none none solid;
	border-color: #04B486;
	padding-left: 5px;
}
.TU_collapse_similarity:hover{
	background: #d0e2de;
}
.TU_collapse_similarity + input {
	display: none;
}
.TU_collapse_similarity + input + div{
	display: none;
}
.TU_collapse_similarity + input:checked + div{
	display: block;
}
.TU_collapse_similarity > a {
	text-decoration: none;
	color: gray;
}
.TU_similar {
	padding-left: 2%;
	text-align: justify;
	text-justify: inter-word;
	border-style: none none none solid;
	border-color: #04B486;
}
.TU_similar > a {
	text-decoration: none;
	color: gray;
}

ul { 
	list-style-type: none;
	padding: 0;
	margin: 0;
}
ul li > a {
	text-decoration: none;
	color: gray;
}
ul li:hover, ul li:focus {
	background: #F0F0F0;
}

ul li:first-child span {
  border-left:none;  
}

</style>
<html>
<head>
<meta charset="utf-8">
<title>TF properties - XapR</title>
<meta name="theme-color" content="#ffffff">
</head>
<body>
	<div class="banner">
		<center><font color="white" size="16px" face="arial">XapR</font></center>
	</div>
	<div align="center" class="main-content">
		<div class="spacer">
	</div><br>			<label class="collapse_ACT" for="_1"><font size="5px">XapR transcriptional activity</font></label>
				<input id="_1" type="checkbox">
				<div class="ACT"><br><ul><li>Among these predicted targets under the direct control of RgrR , as many as 11 genes are included , including PgrR , LeuO , YagP , MarR , YpdA , XapR , YhgF , GadX and IdnR ( indicated in star in Table 1 ) , indicating that a number of genes must be regulated indirectly by PgrR .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=23301696" target="_blank">23301696</a>]<br></li>
<li>To ﬁnd whether ( deoxy ) ade-nosine is the actual inducer in the XapR mutants or whether the deaminated product ( deoxy ) inosine is the inducer , we introduced an add mutation in the XapR mutants .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10400599" target="_blank">10400599</a>]<br></li>
<li>XapA induction by xanthosine in XapR mutants .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10400599" target="_blank">10400599</a>]<br></li>
<li>The ﬁnding that induction by xanthosine in all four mutant classes gives similar activities of XapA or b-galactosidase ( Tables 3 and 4 ) indicates that all mutants have similar levels of XapR protein .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10400599" target="_blank">10400599</a>]<br></li>
<li>XapR regulates the expression of xanthosine phosphorylase ( XapA ) , a purine nucleoside phosphorylase in Escherichia coli .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10400599" target="_blank">10400599</a>]<br></li>
<li>In the wild type , full expression of XapA requires both a functional XapR protein and the inducer xanthosine .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10400599" target="_blank">10400599</a>]<br></li>
<li>However , if full induction of xapA requires the binding of two or more XapR molecules , then a high concentration of xapA genes could titrate XapR .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7559336" target="_blank">7559336</a>]<br></li>
<li>Both XapB and XapR are necessary for full induction of XapA ( 24 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10400599" target="_blank">10400599</a>]<br></li>
<li>When xapR is overexpressed in wild-type cells , the XapA activity increases eightfold , indicating that the concentration of XapR is not sufﬁcient for full induction of xapA .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7559336" target="_blank">7559336</a>]<br></li>
<li>None of the isolated XapR mutants have gained the ability to induce xapA in the presence of guanosine .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10400599" target="_blank">10400599</a>]<br></li>
<li>This expression also depended on the presence of the XapR protein , since only a two - to threefold induction took place in SØ6444 ( pGD111 ) and no induction was found in SØ6447 ( pGD111 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7559336" target="_blank">7559336</a>]<br></li>
<li>The genes xapA and xapB form an operon , and their expression was strictly dependent on the presence of both the XapR protein and the inducer xanthosine .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7559336" target="_blank">7559336</a>]<br></li>
<li>Expression of the xapB-lacZ fusion also strictly depended on the presence of both xanthosine and XapR ( pGD112 and pGD116 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7559336" target="_blank">7559336</a>]<br></li>
<li>Transcription was observed only in the presence of both xanthosine and XapR .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7559336" target="_blank">7559336</a>]<br></li>
<li>These results agree well with those of the primer extension experiments , in which xapA promoter transcripts were seen only in the presence of both XapR protein and xanthosine while xapR promoter transcripts were seen in the absence of XapR protein and xanthosine .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7559336" target="_blank">7559336</a>]<br></li>
<li>In contrast to the case for xapA and xapB , the expression of the xapR-lacZ fusion ( pGD114 ) was not dependent on either xanthosine or XapR protein , since the same level of b-galactosi-dase activity ( ranging from 1,323 to 1,751 U/mg of protein ) was found in all three strains .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7559336" target="_blank">7559336</a>]<br></li>
<li>In the primer extension experiment , both promoters were active in the absence of XapR and xanthosine ( Fig. 5B ) , and the xapR-lacZ fusion gave the same level of b-galactosi-dase activity in the presence or absence of xanthosine in the wild type and in SØ6444 or SØ6447 , in which no XapR protein is synthesized .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7559336" target="_blank">7559336</a>]<br></li>
<li>This suggests that the presence of an amino group at position 2 in the nucleotide base prevents binding to XapR .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10400599" target="_blank">10400599</a>]<br></li>
<li>This indicates that the oxo-group at position 6 , which is also present in xanthosine , is important for binding to XapR .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10400599" target="_blank">10400599</a>]<br></li>
<li>The oxo-group at position 2 in xanthosine is less important for binding to XapR , since mutations leading to the recognition of inosine are common .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10400599" target="_blank">10400599</a>]<br></li>
<li>The XapR is a regulatory protein which in association with xanthosine activates the xapAB operon ( xanthosine catabolism ) and is reported to be constitutive ( Seeger et al. 1995 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=16205910" target="_blank">16205910</a>]<br></li>
<li>The identiﬁcation of the XapR binding sites is currently under investigation , but this has proved to be difﬁcult because the XapR protein aggregates when it is overproduced .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7559336" target="_blank">7559336</a>]<br></li>
<li>It is also possible that the inducers bind to the mutated XapR protein , changing the structure of the protein and making it less active .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10400599" target="_blank">10400599</a>]<br></li>
<li>We can not exclude the possibility that differences in XapR protein stability account for this lower activity .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10400599" target="_blank">10400599</a>]<br></li>
				</div></ul><br>
			<label class="collapse_DOM" for="_2"><font size="5px">XapR protein domains</font></label>
				<input id="_2" type="checkbox">
				<div class="DOM"><br><ul><li>Sequencing of the mutants has revealed that two regions in XapR are important for correct interactions between the inducer and XapR .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10400599" target="_blank">10400599</a>]<br></li>
<li>The results described here show that two regions in XapR , and probably also in other LysR-family proteins , are important for correct interactions between the inducer and the protein .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10400599" target="_blank">10400599</a>]<br></li>
<li>This suggests that the presence of an amino group at position 2 in the nucleotide base prevents binding to XapR .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10400599" target="_blank">10400599</a>]<br></li>
<li>Of the 60 N-terminal amino acids in XapR and AlsR , 68 % are identical .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10400599" target="_blank">10400599</a>]<br></li>
<li>The isolated mutants all contain single-amino-acid substitutions in XapR .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10400599" target="_blank">10400599</a>]<br></li>
				</div></ul><br>
			<label class="collapse_EVO" for="_3"><font size="5px">XapR evolution</font></label>
				<input id="_3" type="checkbox">
				<div class="EVO"><br><ul><li>The amino acid sequence of XapR is highly homologous ( 70 % ) to that of AlsR from E. coli .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10400599" target="_blank">10400599</a>]<br></li>
<li>Of the 60 N-terminal amino acids in XapR and AlsR , 68 % are identical .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10400599" target="_blank">10400599</a>]<br></li>
<li>XapB shows strong similarity to the nucleoside transport protein NupG ( see below ) , and XapR shows homology to the other members of the LysR family of transcriptional activators , as already described by Brun et al. ( 6 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7559336" target="_blank">7559336</a>]<br></li>
<li>XapR belongs to the LysR family of regulatory proteins ( 21 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10400599" target="_blank">10400599</a>]<br></li>
<li>The XapR protein is a member of the LysR family , which comprises more than 50 proteins ( 13 , 37 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7559336" target="_blank">7559336</a>]<br></li>
				</div></ul><br>
			<label class="collapse_RP" for="_4"><font size="5px">Processes regulated by XapR</font></label>
				<input id="_4" type="checkbox">
				<div class="RP"><br><ul><li>XapR regulates the expression of xanthosine phosphorylase ( XapA ) , a purine nucleoside phosphorylase in Escherichia coli .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=10400599" target="_blank">10400599</a>]<br></li>
<li>Genes transcribed more efﬁciently in the presence of EsS Genes and Gene product b promoter regions a Transcription levels ( EsS/Es70 ratio ) d Stress response yieF sE ( 59 ) ; sS ( 19 ) sS , RcsBA ( 60 ) sS , RcsBA ( 60 ) Chromate reductase b3713 N.A. 1.50 1.51 osmB Intergenic region including osmB promoter Osmolarity-inducible lipoprotein b1283 b2688 1.51 2.21 gshA g-glutamate -- cysteine ligase ( glutathione-biosynthesis ) ahpF Alkyl-peroxidase reductase pphA Protein phosphatase macA Macrolide resistance efﬂux pump DNA and RNA-metabolism and modiﬁcation ppk Polyphosphate kinase , part of RNA degradosome , Intergenic region including xapA promoter xapA Xanthosine phosphorylase , nucleotide-synthesis/degradation gyrB B subunit of DNA gyrase recT Rac prophage , recombinase , in recET-lar-ydaCQ operon lar Rac prophage , restriction alleviation and modiﬁcation enhancement , in recET-lar-ydaCQ operon ydaC Rac prophage , in recET-lar-ydaCQ operon ydaQ Rac prophage , possible recombinase , in recET-lar-ydaCQ operon Polyamine-metabolism puuB g-glutamyl -- putrescine oxidase gabD Succinate semialdehyde dehydrogenase speB Agmatinase ( in arginine/putrescine-degradation pathway ) Transcription regulation Intergenic region including appY promoter appY Regulator of hyaABCDEF operon yciT Putative deoR-type transcription regulator ilvY Regulator of ilvC operon rhaS Regulator of rhamnose-transport Sugar metabolism treF Trehalase OxyR ( 61 ) sH ( 62,63 ) b0606 b1838 b0878 1.52 1.54 1.54 Regulator of intracellular sS concentrations ( 3 ) XapR ( 64 ) XapR ( 64 ) b2501 1.50 N.A. b2407 1.62 1.56 b3699 b1349 1.65 1.93 Fis ( 65 ) sS-Dependent in bioﬁlm cells ( 18 ) - growing b1348 1.93 b1347 b1346 1.74 1.66 as recT as recT sS ( 19 ) b1301 b2661 b2937 1.61 1.65 1.66 sS , Nac ( 9,66 ) 1.69 1.51 1.56 1.75 1.81 N.A. b0564 b1284 b3773 b3905 H-NS ( 67 ) H-NS ( 67 ) CRP ( 29 ) ; RhaS ( 68 ) sS ( 9,19 ) sS ( 19 ) sS ( 7 ) 1.53 1.55 1.56 1.57 b3519 b4230 b1897 b1901 ytfT Putative galactose ABC transporter otsB Trehalose-6-phosphate phosphatise araF Arabinose transporter , component of an ABC transport system glgP Glycogen phosphorylase , part of glgCAP operon gpmM Putative 2,3-bisphosphoglycerate mutase glvC Sugar transport phosphotransferase Other metabolic functions Intergenic region including hyaABCDEF promoter hyaA Hydrogenase small subunit ; in hyaABCDEF operon ( 69 ) ; sS ( 19 ) CRP , AraC CRP ( 70 ) ; sS controls glgCAP operon ( 19 ) 1.60 b3428 1.61 1.79 b3612 b3683 2.02 N.A. sS , AppY , anaerobic regulation by ArcA and NarP/NarL ( 20,71,72 ) as hyaA 1.68 b0972 Hydrogenase large subunit ; in hyaABCDEF operon Hydrogenase subunit ( nickel-binding protein ) ; in hyaABCDEF operon SecY-interacting protein Acetyl-muramic acid permease Transcriptional repressor of murQP Trans-aconitate methylatransferase Predicted oxidoreductase , Fe-S protein ; in ydhYVWXUT operon Predicted oxidoreductase , Fe-S protein ; in ydhYVWXUT operon hyaB 1.66 b0973 as hyaA hyaF 1.50 b0977 syd 1.59 1.59 1.62 1.60 b2793 b2429 b2427 b1519 murP murR tam CRP , MurR ( 73 ) sS ( 74 ) ydhY FNR , NarL ( 75 ) 1.80 b1674 FNR , NarL ( 75 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=21398637" target="_blank">21398637</a>]<br></li>
				</div></ul><br>
			<label class="collapse_SIT" for="_5"><font size="5px">XapR binding site</font></label>
				<input id="_5" type="checkbox">
				<div class="SIT"><br><ul><li>The pGD56 primer ( 59-GCCAGCATTTCATAACCAACC , complementary to pCP10 downstream of the cloning sites starting 73 nucleotides downstream of the XapR ATG start codon ) was used to synthesize cDNA from RNA extracted from SØ6444 ( pCP10 ) and SØ6444 ( pCP19 ) .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7559336" target="_blank">7559336</a>]<br></li>
<li>These sites are centered at positions 240 and 2120 relative to the transcription start site of xapAp and are good candidates for the target of the XapR protein .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7559336" target="_blank">7559336</a>]<br></li>
				</ul></div><br>
			<label class="collapse_TU" for="_6"><font size="5px">Transcription unit regulated by XapR</font></label>
				<input id="_6" type="checkbox">
				<div class="TU"><br><ul><li>The genes xapA and xapB form an operon , and their expression was strictly dependent on the presence of both the XapR protein and the inducer xanthosine .	[<a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=7559336" target="_blank">7559336</a>]<br></li>
				</div></ul></div><br>
	</div>
</body>
</html>